NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Medical Properties Trust secures $800 million UK financing

Published 25/05/2024, 01:02 am
© Reuters.
MPW
-

BIRMINGHAM, Ala. - Medical Properties Trust, Inc. (NYSE: NYSE:MPW), a self-advised real estate investment trust, announced today the completion of an $800 million financing deal involving a selection of its U.K. hospital real estate assets. The non-recourse, non-amortizing secured financing was provided by a group of global institutional, insurance, and pension investors, led by European investment firm Song Capital.

The transaction encompasses 27 of the 36 facilities leased to Circle Health in the United Kingdom, with the loan-to-value ratio set in the low-40% range. This suggests a valuation increase of approximately 20% from when the majority of these properties were acquired by Medical Properties Trust around four years ago. The 10-year loan has a fixed cash pay rate of 6.9%, not including debt issuance costs.

Edward K. Aldag, Jr., Chairman, President, and CEO of Medical Properties Trust, highlighted the significance of this financial move, stating that the company has raised $2.4 billion in liquidity in the first five months of the year, surpassing its initial target of $2.0 billion. Aldag emphasized the favorable terms of the financing, which demonstrate the company's capability to secure long-term borrowing costs below market-implied rates and extend the duration of its debt maturities.

The proceeds from the financing are intended for debt repayment, including a £105 million secured term loan due in December 2024, borrowings under its revolving credit facility, and part of its GBP term loan maturing in early 2025. The funds will also support general corporate purposes.

Legal advisory for the transaction was provided to Medical Properties Trust by Goodwin Procter (UK) LLP, while Song Capital received counsel from Slaughter and May, CBRE, and Rothschild & Co.

Medical Properties Trust, established in 2003 in Birmingham, Alabama, has grown to become one of the world's largest owners of hospital real estate. As of March 31, 2024, the company owns 436 facilities with approximately 43,000 licensed beds across nine countries and three continents.

This announcement is based on a press release statement.

InvestingPro Insights

Medical Properties Trust, Inc. (MPW) has recently completed a substantial financing deal, which underscores the company's strategic financial management. According to InvestingPro data, MPW has a market capitalization of $3.03 billion, a notable figure that reflects its position in the market. Despite a challenging revenue growth of -47.28% over the last twelve months as of Q1 2024, the company boasts a high gross profit margin of 95.13%, indicating efficient cost management relative to its revenues.

In terms of shareholder returns, MPW presents a compelling dividend yield of 11.9%, which is particularly attractive for income-focused investors. Moreover, the company has a track record of maintaining dividend payments for 20 consecutive years, as highlighted in one of the InvestingPro Tips. This consistency in returning value to shareholders may offer some reassurance about the company's commitment to its dividend policy, even in volatile market conditions.

Another InvestingPro Tip points out that MPW is trading at a low Price / Book multiple of 0.44, suggesting that the stock may be undervalued compared to the company's book value. This metric, coupled with the significant dividend yield, could signal a potential opportunity for investors seeking value plays with income generation.

For readers looking to delve deeper into the financial health and future prospects of Medical Properties Trust, there are additional InvestingPro Tips available, which can be accessed through InvestingPro's platform. Use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, and discover the full range of insights, including 13 more tips for MPW, that could help inform your investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.